SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Guardant Health has filed a notice of a proposed sale of common stock valued at approximately $5.8 million, executed under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is of low materiality, representing less than 0.05% of both the company's market capitalization and its shares outstanding, suggesting a neutral market impact.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Monroe Terilyn J.
CIK	0001652956
Title/Position	Not Specified
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-12-01 (Approximate)
Transaction Code	S (Proposed Sale)
Security Type	Common Stock
Shares Involved	55,167
Price Per Share	~$105.97 (Aggregate)
Total Value	$5,846,164
Shares Owned After	Not Specified
Ownership Type	Not Specified

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$5,846,164
% of Market Cap	0.048%
Shares Transacted	55,167
% of Shares Outstanding	0.044%
Post-Transaction Ownership	Not Specified
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The ~$5.8M sale is minor compared to Guardant Health's $12.26 billion market capitalization.
• Transaction Significance: The sale represents a very small fraction of the company's total equity (0.044% of outstanding shares), indicating a negligible impact on the overall ownership structure and minimal potential for market disruption.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is of low materiality and was conducted under a 10b5-1 trading plan adopted on August 2, 2025. Such plans allow insiders to sell shares at predetermined times to avoid accusations of trading on non-public information, making them poor indicators of an insider's current outlook on the company.

Volume & Sentiment

• Expected Volume Impact: Minimal. The number of shares is unlikely to significantly affect daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by officers for financial planning or diversification are routine and do not typically carry a bullish or bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates a plan adoption date of August 2, 2025, which points to this being a sale under a Rule 10b5-1 trading plan.